Switch theme
Sign up to access all valuation multiples
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.
2017
196
LTM Revenue $7.6M
LTM EBITDA -$255M
$2.4B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Scholar Rock has a last 12-month revenue of $7.6M and a last 12-month EBITDA of -$255M.
In the most recent fiscal year, Scholar Rock achieved revenue of n/a and an EBITDA of -$250M.
Scholar Rock expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Scholar Rock valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | n/a | n/a | XXX | XXX | XXX |
| Gross Profit | n/a | n/a | XXX | XXX | XXX |
| Gross Margin | NaN% | NaN% | XXX | XXX | XXX |
| EBITDA | -$168M | -$250M | XXX | XXX | XXX |
| EBITDA Margin | -Infinity% | -Infinity% | XXX | XXX | XXX |
| Net Profit | -$135M | -$166M | XXX | XXX | XXX |
| Net Margin | -Infinity% | -Infinity% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Scholar Rock's stock price is $29.
Scholar Rock has current market cap of $2.7B, and EV of $2.4B.
See Scholar Rock trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.4B | $2.7B | XXX | XXX | XXX | XXX | $-2.43 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Scholar Rock has market cap of $2.7B and EV of $2.4B.
Scholar Rock's trades at 311.6x LTM EV/Revenue multiple, and -9.3x LTM EBITDA.
Analysts estimate Scholar Rock's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Scholar Rock and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $2.4B | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | XXX | XXX |
| EV/EBITDA | -9.5x | XXX | XXX | XXX |
| P/E | -11.1x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -11.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpScholar Rock's NTM/LTM revenue growth is 849%
Scholar Rock's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged $1.3M for the same period.
Over next 12 months, Scholar Rock's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Scholar Rock's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Scholar Rock and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | XXX | XXX | XXX |
| EBITDA Growth | 48% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | $1.3M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | n/a | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Scholar Rock acquired XXX companies to date.
Last acquisition by Scholar Rock was XXXXXXXX, XXXXX XXXXX XXXXXX . Scholar Rock acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Scholar Rock founded? | Scholar Rock was founded in 2017. |
| Where is Scholar Rock headquartered? | Scholar Rock is headquartered in United States of America. |
| How many employees does Scholar Rock have? | As of today, Scholar Rock has 196 employees. |
| Who is the CEO of Scholar Rock? | Scholar Rock's CEO is Dr. Jay T. Backstrom, M.D.,M.P.H.. |
| Is Scholar Rock publicy listed? | Yes, Scholar Rock is a public company listed on NAS. |
| What is the stock symbol of Scholar Rock? | Scholar Rock trades under SRRK ticker. |
| When did Scholar Rock go public? | Scholar Rock went public in 2018. |
| Who are competitors of Scholar Rock? | Similar companies to Scholar Rock include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of Scholar Rock? | Scholar Rock's current market cap is $2.7B |
| What is the current revenue of Scholar Rock? | Scholar Rock's last 12-month revenue is $7.6M. |
| What is the current EBITDA of Scholar Rock? | Scholar Rock's last 12-month EBITDA is -$255M. |
| What is the current EV/Revenue multiple of Scholar Rock? | Current revenue multiple of Scholar Rock is 311.6x. |
| What is the current EV/EBITDA multiple of Scholar Rock? | Current EBITDA multiple of Scholar Rock is -9.3x. |
| Is Scholar Rock profitable? | Yes, Scholar Rock is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
